Action A204840 GL PHARM TECH CORP.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues GL Pharm Tech Corp.

Actions

A204840

KR7204840003

Cours en clôture Korea S.E.
Autres places de cotation
 00:00:00 11/06/2024 		Varia. 5j. Varia. 1 janv.
1 162 KRW -0,85 % Graphique intraday de GL Pharm Tech Corp. -1,86 % +2,29 %
03/05 Un acheteur dont l'identité n'a pas été révélée a acquis 3,23 % des parts de GL Pharm Tech Corp. (KOSDAQ:A204840) auprès d'Ideal Private Equity Fund pour 3,97 milliards de KRW. CI
06/03 W Science Co. a conclu l'acquisition d'une participation de 14,75 % dans GL Pharm Tech Corp. (KOSDAQ:A204840) auprès d'Ideal Private Equity Fund. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
An undisclosed buyer acquired 3.23% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund for KRW 3.97 billion.
W Science Co., Ltd. completed the acquisition of 14.75% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund
GL Pharm Tech Corp. announced that it has received KRW 9.199999458 billion in funding from W Science Co., Ltd.
GL Pharm Tech to Raise 9.2 Billion Won via Share Issuance; Shares Decline 7%
GL Pharm Tech Corp. announced that it expects to receive KRW 9.199999458 billion in funding from W Science Co., Ltd.
W Science Co., Ltd. agreed to acquire a 14.7% stake in GL Pharm Tech Corp.
GL Pharm Tech Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
GL Pharm Tech Corp. Auditor Raises 'Going Concern' Doubt
GL Pharm Tech Corp. Auditor Raises 'Going Concern' Doubt
GL Pharm Tech Corp. announced that it expects to receive KRW 8.999999634 billion in funding from Ideal Private Equity Fund
GL Pharm Tech Corp. announced that it has received KRW 1.000000232 billion in funding from Kyperion Co., Ltd.
GL Pharm Tech Corp. announced that it expects to receive KRW 1.000000232 billion in funding from Kyperion Co., Ltd.
GL Pharm Tech Corp. announced that it has received KRW 1.000000534 billion in funding from Kuhnil Pharmaceutical Co., Ltd.
GL Pharm Tech Corp. announced that it expects to receive KRW 1.000000534 billion in funding from Kuhnil Pharmaceutical Co., Ltd.
GL Pharm Tech Corp. announced that it has received KRW 3.1 billion in funding from Unione Communications Co., Ltd.
GL Pharm Tech Corp. announced that it expects to receive KRW 3.1 billion in funding from Unione Communications Co., Ltd. and other investors
Crown Pharm Co., Ltd. announced that it has received KRW 1.00001 billion in funding from GL Pharm Tech Corp.
Crown Pharm Co., Ltd. announced that it has received KRW 3.00003 billion in funding from GL Pharm Tech Corp.
GL Pharm Tech Corp. announced that it has received KRW 7 billion in funding from Shinhan Investment Corp., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, E&INVESTMENT INC. and other investors
GL Pharm Tech Corp. announced that it expects to receive KRW 7 billion in funding from Shinhan Investment Corp., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, E&INVESTMENT INC., and other investors
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A204840
  4. Actualités GL Pharm Tech Corp.
  5. Autres langues